Tokyo, Japan

Fumiaki Matsuura


Average Co-Inventor Count = 12.9

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 1982

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Fumiaki Matsuura: Innovator in Pharmaceutical Compounds

Introduction

Fumiaki Matsuura is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative compounds aimed at addressing critical health issues. With a total of 2 patents to his name, Matsuura's work is recognized for its potential impact on medical treatments.

Latest Patents

Matsuura's latest patents include a nicotinamide derivative and a novel compound, 1,2-bis(nicotinamido)propane, along with its pharmaceutically acceptable salts. These inventions are designed to prevent or alleviate cerebral vasospasms, reduce the risk of cerebral apoplexy, and lower lipoperoxide levels in the blood. Another significant patent involves a tetrahydronicotinamide derivative, which has demonstrated actions for suppressing platelet aggregation, as well as anti-inflammatory, antipyretic, and analgesic properties.

Career Highlights

Fumiaki Matsuura is currently associated with Chugai Seiyaku Kabushiki Kaisha, a prominent pharmaceutical company. His work at Chugai has allowed him to focus on developing innovative solutions that address various health challenges. Matsuura's dedication to research and development has positioned him as a key figure in the pharmaceutical industry.

Collaborations

Matsuura has collaborated with notable colleagues, including Takashi Mori and Sakae Takaku. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to the development of groundbreaking pharmaceutical compounds.

Conclusion

Fumiaki Matsuura's contributions to the field of pharmaceuticals through his patents and collaborations highlight his commitment to advancing medical science. His innovative work continues to pave the way for new treatments that can significantly improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…